Human studies have revealed that sTNFR1, sTNFR2, and KIM-1 are strong prognostic markers for incident and progressive CKD in persons with type 1 and type 2 diabetes mellitus in the ambulatory setting. The gene discussed is HAVCR1; the disease is diabetes mellitus.